Global /United Kingdom /Healthcare /Medical Care Facilities /TCF

Theracryf Plc

TCF

• LSE: TCF • Delayed

0.2200GBX -4.4%

0.0030 USD

As of 5 June 2026, Theracryf Plc has a market cap of $6.63M USD, ranking #43319 globally and #988 in the United Kingdom. It ranks #3834 in the Healthcare sector, and #461 in the Medical Care Facilities industry.

Global Rank

43319

Country Rank

988

Sector Rank

3834

Industry Rank

461

Key Stats

Market Cap

$6.63MUSD

4.94M GBP

Enterprise Value

$1.94MUSD

1.45M GBP

EBITDA (TTM)

-$2.96MUSD

-2.21M GBP

Net Income (TTM)

-$2.7MUSD

-2.01M GBP

PB Ratio

1.0

Company Profile

Country (HQ)

United Kingdom

Sector

Healthcare

Industry

Medical Care Facilities

CEO

Huw Jones open_in_new

Employees

Founded

2014

Website

theracryf.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-4.4%	-4.2%	18%	9.5%	9.5%	15%	2.2%	-94%	-97%

News

Markets

Exchange	Ticker	Price	Quotes
London Stock Exchange (LSE / LON) MIC: XLON PRIMARY	TCF TheraCryf PLC ISIN: GB00BSVYN304 Shares Out.: Shares Outstanding: 2.149B¹ Shares Float: 1.241B² TV: TradingView: LSE: TCF SA: Stock Analysis: LON: TCF YF: Yahoo Finance: TCF.L GF: Google Finance: LON: TCF BA: Barron's: TCF MS: Morningstar: XLON: TCF	0.2200 GBX	TV: TradingView: LSE: TCF SA: Stock Analysis: LON: TCF YF: Yahoo Finance: TCF.L GF: Google Finance: LON: TCF BA: Barron's: TCF MS: Morningstar: XLON: TCF

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Theracryf Plc

Theracryf Plc, a clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioural brain disorders. The company develops orexin-1 antagonist for the treatment of binge eating disorder and anxiety; and atypical dopamine transporter inhibitor (DAT) to treat fatigue and narcolepsy. It also develops SFX-01 for the treatment of brain cancer glioblastoma and neurodevelopmental disorders. The company was formerly known as Evgen Pharma plc and changed its name to Theracryf Plc in April 2024. Theracryf Plc was incorporated in 2014 and is headquartered in Nether Alderley, the United Kingdom.

Similar Companies

Industry: Medical Care Facilities (United Kingdom)

Name	Market Cap (USD) diff.	PE	Country
CVS Group plc LSE: CVSG	$1.1B 816.62M GBP 16K%	50.8	United Kingdom
Spire Healthcare Group plc LSE: SPI	$863.18M 643.36M GBP 13K%	40.2	United Kingdom
NIOX Group Plc LSE: NIOX	$381.3M 284.2M GBP 6K%	41.2	United Kingdom
Kooth plc LSE: KOO	$63.99M 47.7M GBP 865%	18.8	United Kingdom
EDX Medical Group PLC LSE: EDX	$60.78M 45.3M GBP 817%	-	United Kingdom
One Health Group Plc LSE: OHGR	$46.67M 34.79M GBP 604%	-	United Kingdom

Industry: Medical Care Facilities (Global)

Name	Market Cap (USD) diff.	PE	Country
International Holding Company PJSC ADX: IHC	$232.22B 852.82B AED 4M%	44.1	United Arab Emirates
HCA Healthcare, Inc. NYSE: HCA	$96.73B 1M%	14.9	United States
Fresenius SE & Co. KGaA XETRA: FRE	$26.65B 22.97B EUR 402K%	15.0	Germany
Koninklijke Philips N.V. AMS: PHIA	$25.54B 22.02B EUR 385K%	24.9	Netherlands
Dr. Sulaiman Al Habib Medical Services Group Co. TADAWUL: 4013	$22.47B 84.42B SAR 339K%	35.2	Saudi Arabia
Labcorp Holdings Inc. NYSE: LH	$21.13B 319K%	24.6	United States

chevron_leftBack